Martin Nitschke

Validation of treatment strategies for enterohaemorrhagic Escherichia coli O104:H4 induced haemolytic uraemic syndrome: case-control study

Jan Menne, Martin Nitschke, Robert Stingele et al. · BMJ · 2012 · 306 citations · Full text

Medicine, Infectious Diseases, Pharmacotherapy +9

Development and validation of a renal risk score in ANCA-associated glomerulonephritis

Silke R. Brix, Mercedes Noriega, Pierre Tennstedt et al. · Kidney International · 2018 · 293 citations

Medicine, Internal Medicine, Nephrology +11

Results from part A of the multi-center, double-blind, randomized, placebo-controlled NefIgArd trial, which evaluated targeted-release formulation of budesonide for the treatment of primary immunoglobulin A nephropathy

Jonathan Barratt, Richard Lafayette, Jens Kristensen et al. · Kidney International · 2022 · 215 citations · Full text

Pharmacy, Nephrology, Pharmacotherapy +13

Sparsentan in patients with IgA nephropathy: a prespecified interim analysis from a randomised, double-blind, active-controlled clinical trial

Hiddo J.L. Heerspink, Jai Radhakrishnan, Charles E. Alpers et al. · The Lancet · 2023 · 215 citations · Full text

Medicine, Internal Medicine, Nephrology +12

Valganciclovir Prophylaxis Versus Preemptive Therapy in Cytomegalovirus-Positive Renal Allograft Recipients: 1-Year Results of a Randomized Clinical Trial

Oliver Witzke, Ingeborg A. Hauser, Michael Bartels et al. · Transplantation · 2011 · 175 citations

Medicine, Infectious Diseases, Nephrology +16